Lateral Flow Assay Market Worth $8.7 Billion by 2023 - Exclusive Report by MarketsandMarkets™

Lateral Flow Assay Market Worth $8.7 Billion by 2023 - Exclusive Report by MarketsandMarkets™

PR Newswire

CHICAGO, November 13, 2018

CHICAGO, November 13, 2018 /PRNewswire/ --

According to the new market research report "Lateral Flow Assay Market by Application (Clinical Testing (Pregnancy, Infectious Disease (Mosquito , Influenza, STI, Hepatitis, TB), Cardiac Marker, Lipid Test) Veterinary, Food Safety) Product (Reader, Kits) Technique, End User - Global Forecast to 2023" , published by MarketsandMarkets™, the Lateral Flow Assay Market is expected to reach USD 8.7 billion by 2023 from an estimated USD 6.0 billion in 2018, at a CAGR of 7.7%.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Don't miss out on business opportunities in Lateral Flow Assay Market.

Speak to Our Analyst and gain crucial industry insights that will help your business grow:

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=167205133

The high prevalence of infectious diseases worldwide, rapidly growing geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices are the significant growth drivers of the Lateral Flow Assay Market.

The lateral flow readers segment is expected to grow at the highest CAGR in global lateral flow assays market during the forecast period 

On the basis of product, the Lateral Flow Assay Market is segmented in kits & reagents and lateral flow readers. The kits and reagents segment is accounted for the largest share of the global Lateral Flow Assay Market in 2017. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for point-of-care testing, growing burden of chronic diseases, and increasing use of lateral flow kits in home care.

Browse in-depth TOC on "Lateral Flow Assay Market"

249 - Tables  

56 - Figures  

288 - Pages 

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/lateral-flow-assay-market-167205133.html

"By application, the clinical testing segment held the largest market share in 2017." 

Based on application, the clinical/point-of-care testing segment accounted for the largest share of the Lateral Flow Assay Market. The rise in population levels & prevalence of chronic diseases, growing pressure to reduce healthcare costs, and increasing demand for patient-centric care are the major factors driving the growth of the clinical testing market.

"North America dominated the market in 2017." 

North America accounted for the largest share of the Lateral Flow Assay Market in 2017, followed by Europe and Asia Pacific. The presence of a highly developed healthcare system, rising geriatric population, increasing incidence of chronic diseases, quick adoption of new innovative products, and a large number of lateral flow assay kits manufacturing companies in this region are the major factors responsible for the largest share of North America in the Lateral Flow Assay Market.

Request for Free Sample Report @  

https://www.marketsandmarkets.com/requestsampleNew.asp?id=167205133

The prominent players in the global Lateral Flow Assay Market are Abbott Laboratories (US), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (US), Siemens AG (Germany), Becton and Dickinson Company (US), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (The Netherlands), PerkinElmer, Inc. (US), Hologic, Inc. (US), Merck Millipore (US), Quidel Corporaton (US), Abcam plc. (US), DCN Diagnostics (US), Surmodics, Inc. (US), BioPorto Diagnostics A/S (Denmark), Chembio Diagnostic Systems, Inc. (US), Polysciences, Inc. (US), Innova Biosciences Ltd. (UK), Microcoat Biotechnologie GmbH (Germany), Senova GmbH (Germany), Scienion AG (Germany), and Orasure Diagnostics (US).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com


Research Insight: https://www.marketsandmarkets.com/ResearchInsight/lateral-flow-assay-market.asp

Visit Our Website: https://www.marketsandmarkets.com


Voltar noticias em Inglês